The Native Antigen
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Lgc Unit 3, Kidlington, Oxfordshire, Uni...Phone Number
+44 1865595230Revenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About The Native Antigen
The Native Antigen Company specializes in the development and manufacture of high-quality antigens and antibodies for viral and bacterial pathogens, catering to the diagnostic and biopharmaceutical industries. They offer a range of services including custom projects for antigen production, antibody generation, and immunoassay development, supported by a team of experienced molecular biologists. Their proprietary VirtuE expression system is designed to produce native-like proteins essential for accurate research and development. The company is committed to expanding its portfolio to include critical reagents for human health, addressing emerging infectious diseases.Explore more
The Native Antigen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is The Native Antigen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at The Native Antigen
Funding: Get notified immidiatlly once The Native Antigen has new funding data
The Native Antigen, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on The Native Antigen recently announced quarterly report
Check if The Native Antigen has recently received funding, and reach out quickly before it becomes old news!
Check out if The Native Antigen is spiking on competitors!
Click to see if The Native Antigen had a recent Job posting/layoffs
Product Launch: Get notified when The Native Antigen launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to The Native Antigen
Compare insights from companies similar to The Native Antigen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
The Native Antigen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
The Native Antigen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about The Native Antigen.
The Native Antigen Tech Stack
A closer look at the technologies used by The Native Antigen
The Native Antigen News & Media
The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio
OXFORD, England--(BUSINESS WIRE)--The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team. Richard White has joined the Company as Business Development Manager, and Pardeep Sharda as Senior Product Manager. The appointments follow the Native Antigen Company’s recent move to new state-The Native Antigen Company Introduces New Range of Influenza Antigens
OXFORD, England--(BUSINESS WIRE)--The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season. The latest influenza antigens will help support development of vaccines and diagnostics as part of the ongoing vaccine reformulaThe Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies
OXFORD, England--(BUSINESS WIRE)--The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the introduction of ten new monoclonal antibodies recognising SARS-CoV-2, the causative agent of COVID-19. These ten antibodies recognise different epitopes of the SARS-CoV-2 Spike glycoprotein, nine of which are SARS-CoV-2-Mercia sells stake in Covid-19 antigen producer in GBP18 million deal
Mercia sells stake in Covid-19 antigen producer in GBP18 million deal Submitted 10/07/2020 - 10:07am Specialist asset manager, Mercia Asset Management, has sold its stake in The Native Antigen Company, a leading producer of infectious disease reagents, to global life sciences tools company LGC for a total cash consideration of up to GBP18.0 million. Mercia has supported The Native Antigen Company since it commenced trading, investing from both its own balance sheet and its third-party funds
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding The Native Antigen
Sign Up For FreeTo access detailed company insights
The Native Antigen Company specializes in the development and manufacture of high-quality antigens and antibodies for viral and bacterial pathogens, catering to the diagnostic and biopharmaceutical industries. They offer a range of services including custom projects for antigen production, antibody generation, and immunoassay development, supported... Read More
